By Kaplan-Meier analysis, tumor size was a significant predictor of both overall (p = 0.03) and disease-specific (p = 0.02) mortality. However, tumor size approached but did not attain statistical ...
Median follow-up for all patients was 31 months. Tumor size distribution is illustrated in Figure 1. The overall 5-year survival was 71.1% (95% confidence interval [CI], 63.6 to 78.6% ...
The team reported on the study results in Nature Medicine, in a paper titled, “Digoxin for reduction of circulating tumor cell cluster size in metastatic breast cancer: a proof-of-concept trial ...